Dynavox Group AB DYVOX

Morningstar Rating
SEK 72.10 −1.25 (1.70%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DYVOX is trading at a LOCK|<PTC$ premium.
Price
SEK 72.10
Fair Value
LOCK|.XYQw##
Uncertainty
LOCK|#!!b@
1-Star Price
LOCK|.CxH%g?
5-Star Price
LOCK|.f#<KR
Economic Moat
LOCK|s%
Capital Allocation
—

Trading Information

Previous Close Price
SEK 73.35
Day Range
SEK 71.90–75.80
52-Week Range
SEK 57.20–105.50
Bid/Ask
SEK 72.30 / SEK 72.40
Shares Outstanding
106.07M
Market Cap
SEK 7.65B
Volume/Avg
274,740 / 311,262

Key Statistics

Price/Earnings (Normalized)
25.23
Price/Sales
2.93
Dividend Yield (Trailing)
0.69%
Dividend Yield (Forward)
0.69%
Dividend Payment Schedule
May
Total Yield
0.69%

Company Profile

Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
1,085

Valuation

Metric
DYVOX
Price/Earnings (Normalized)
25.23
Price/Book Value
9.22
Price/Sales
2.93
Price/Cash Flow
15.48
Price/Earnings
DYVOX

Financial Strength

Metric
DYVOX
Quick Ratio
1.20
Current Ratio
1.71
Interest Coverage
8.75
Quick Ratio
DYVOX

Profitability

Metric
DYVOX
Return on Assets (Normalized)
10.75%
Return on Equity (Normalized)
41.26%
Return on Invested Capital (Normalized)
17.59%
Return on Assets
DYVOX

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|X<V#$>dLOCK|rN$166B
Becton Dickinson & Co
BDX
LOCK|%jyLOCK|&@<DP$58B
Alcon Inc
ALC
LOCK|@H#fKvLOCK|PZ^Dt$37B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|pkhxSTzLOCK|$fz&f$35B
ResMed Inc
RMD
LOCK|VZ<bT?GLOCK|gqpdF$34B
West Pharmaceutical Services Inc
WST
LOCK|B!>%<<@rLOCK|F<x$27B
Solventum Corp
SOLV
LOCK|!^^C@SXLOCK|k^?$15B
Baxter International Inc
BAX
LOCK|hxLOCK|pvC@m$13B
The Cooper Companies Inc
COO
LOCK|j%%%H^LOCK|rjV%Z$12B
Align Technology Inc
ALGN
LOCK|&FY%dkLOCK|&$<j$$11B

Sponsor Center